Home/Filings/4/0001169245-20-000029
4//SEC Filing

Hanson Kristopher 4

Accession 0001169245-20-000029

CIK 0001169245other

Filed

Feb 13, 7:00 PM ET

Accepted

Feb 14, 6:50 PM ET

Size

5.6 KB

Accession

0001169245-20-000029

Insider Transaction Report

Form 4
Period: 2020-02-12
Hanson Kristopher
Vice President, Head of Legal
Transactions
  • Award

    Employee Stock Option (right to buy)

    2020-02-12+55,00055,000 total
    Exercise: $5.19Exp: 2030-02-12Common Stock (55,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 12, 2020, subject to the reporting person's continued service through each such date.

Issuer

PhaseBio Pharmaceuticals Inc

CIK 0001169245

Entity typeother

Related Parties

1
  • filerCIK 0001789970

Filing Metadata

Form type
4
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:50 PM ET
Size
5.6 KB